| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,367 |
6,711 |
$314K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,069 |
1,896 |
$80K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
988 |
944 |
$76K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,424 |
2,071 |
$60K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
738 |
721 |
$60K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
440 |
406 |
$56K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,924 |
3,609 |
$53K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
563 |
558 |
$49K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
617 |
610 |
$48K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
879 |
840 |
$42K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
419 |
408 |
$32K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,152 |
1,384 |
$29K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
810 |
800 |
$20K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,843 |
2,485 |
$18K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
298 |
292 |
$16K |
| 87634 |
|
209 |
197 |
$12K |
| 87081 |
|
970 |
935 |
$5K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
27 |
27 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
253 |
253 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
29 |
28 |
$2K |
| 86318 |
|
73 |
72 |
$1K |
| 82570 |
|
174 |
170 |
$739.50 |
| 90461 |
|
299 |
299 |
$496.01 |
| 87807 |
|
52 |
48 |
$473.00 |
| 96160 |
|
207 |
205 |
$443.25 |
| 81003 |
|
238 |
230 |
$438.48 |
| 80176 |
|
31 |
29 |
$370.20 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
17 |
12 |
$200.43 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
201 |
192 |
$117.30 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14 |
14 |
$112.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
92 |
85 |
$83.64 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
12 |
12 |
$10.38 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
14 |
13 |
$2.34 |
| 90686 |
|
466 |
463 |
$1.04 |
| 90697 |
|
184 |
184 |
$0.00 |
| 90651 |
|
108 |
108 |
$0.00 |
| 90680 |
|
168 |
167 |
$0.00 |
| 90620 |
|
35 |
35 |
$0.00 |
| 97802 |
|
90 |
89 |
$0.00 |
| 90716 |
|
80 |
80 |
$0.00 |
| 90696 |
|
26 |
26 |
$0.00 |
| 90670 |
|
312 |
310 |
$0.00 |
| 90681 |
|
48 |
48 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
27 |
27 |
$0.00 |
| 90700 |
|
41 |
41 |
$0.00 |
| 90734 |
|
69 |
69 |
$0.00 |
| 90707 |
|
96 |
94 |
$0.00 |
| 90671 |
|
104 |
101 |
$0.00 |
| 90633 |
|
129 |
126 |
$0.00 |
| 90715 |
|
28 |
28 |
$0.00 |
| 90648 |
|
44 |
44 |
$0.00 |
| 90473 |
|
21 |
16 |
$0.00 |